Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)

NCT01251549 · ReWalk Robotics, Inc. · Updated 5 Oct 2016

What is being tested
ReWalk - a motorized exoskeleton suit
For
Paraplegia; Spinal Cord Injuries (SCI)
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 55 years. About 32 people. The full rules are on the registry page.
Where
United States, Italy (2 sites)
When
Starts or started March 2009, ends March 2013. Registered 2 Dec 2010.
Results
None posted yet.

In the researchers' words

ReWalk suit developed by Argo Medical Technologies is designed to enable people with lower limb disabilities to carry out routine ambulatory functions (stand, walk etc.); it can be used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple sclerosis, cerebral palsy and other pathologies that produce severe walking impairments.
ClinicalTrials.gov, NCT01251549

Sites

  • Albert Einstein Medical Center, Moss Rehabilitation CenterElkins Park, Pennsylvania, United States
  • Ospedale Valduce di Como, Centro Villa Beretta ItalyComo, Italy